Sodium-lithium countertransport activity in healthy, dyslipidemic, and hypertensive individuals

Angiology

Volumn 59, Issue 6, 2009, Pages 727-735

  Savopoulos, Christos G ^a   Hatzitolios, Apostolos I ^a,b   Katsiki, Niki A ^a   Baltatzi, Maria ^a   Kosmidou, Maria ^a   Raikos, Nikolaos ^b   Mikhailidis, Dimitri P ^c   Ziakas, Antonios G ^a   Kaiafa, Georgia ^a   Tsesmeli, Niki ^a  

^a ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Dyslipidemia; Hypertension; Sodium lithium countertransport activity; Triglycerides

Indexed keywords

CHOLESTEROL; LITHIUM ION; SODIUM ION; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; ERYTHROCYTE; FEMALE; HUMAN; HYPERTENSION; MALE; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; SYSTOLIC BLOOD PRESSURE; TRANSPORT KINETICS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTIPORTERS; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL; DYSLIPIDEMIAS; ERYTHROCYTES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TRIGLYCERIDES; UP-REGULATION; YOUNG ADULT;

EID: 57749183435     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319708319784     Document Type: Article

References (50)

1. Hunt SC, Williams RR, Smith JB, Ash KO Associations of 3 cation transport with plasma lipids in Utah subjects. Hypertension. 1986 ; 8: 30-36.
2. Adranga NC, Canessa ML, Solomon HS, Slater E., Tosteson DC Red cell sodium-lithium countertransport and sodium-potassium cotransport in patients with essential hypertension. Hypertension. 1982 ; 4: 795-804.
3. Canessa M., Adragna N., Solomon HS, Connolly TM, Tosteson DC Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med. 1980 ; 302: 772-776.
4. Turner ST, Michels VV Sodium-lithium countertransport and hypertension in Rochester, Minnesota. Hypertension. 1991 ; 18: 183-190.
5. Delva P., Pastori C., Degan M., et al. Erythrocyte Na(+)H+ exchanger kinetics and Na(+)- Li+ countertransport activity in essential hypertensive patients. Eur J Clin Invest. 1996 ; 26: 64-70.
6. Fujita T., Noda H., Ando K., Sato Y. Peripheral resistance and red cell Li-Na countertransport in borderline hypertensives. Life Sci. 1983 ; 32: 1621-1627.
7. Strazzullo P., Siani A., Cappuccio FP, et al. Red blood cell sodium-lithium countertransport and risk of future hypertension: the Olivetti Prospective Heart Study. Hypertension. 1998 ; 31: 1284-1289.
8. Mu J., Liu Z., Yang D., Liang Y., Wang Z., Hou R. Baseline Na-Li countertransport and risk of hypertension in children: a 10-year prospective study in Hanzhong children. J Hum Hypertens. 2004 ; 18: 884-890.
9. Sodium and Hypertension Studies. Senior Medical Student/Honors Program in Internal Medicine. Drs. William Lawton and Allyn Mark, University of Iowa, College of Medicine ; 1985-1986.
10. Weder AB, Delgado MC, Zhu X., Gleiberman L., Kan D., Chakravarti A. Erythrocyte sodium-lithium countertransport and blood pressure: a genome-wide linkage study. Hypertension. 2003 ; 41: 842-846.
11. Ragone E., Strazzullo P., Siani A., et al. Ethnic differences in red blood cell sodium/lithium countertransport and metabolic correlates of hypertension: an international collaborative study. Am J Hypertens. 1998 ; 11 (8 Pt). 935-941.
12. Cirillo M., Laurenzi M., Panarelli W., Trevisan M., Stamler J. Prospective analysis of traits related to 6-year change in sodium-lithium countertransport. Gubbio Study Collaborative Research Group. Kidney Int. 2000 ; 58: 1211-1218.
13. Winocour PH, Thomas TH, Brown L., Laker MF, Wilkinson R., Alberti KG Serum triglyceride and insulin levels are associated with erythrocyte sodium-lithium counter-transport activity in normoglycaemic individuals. Clin Chim Acta. 1992 ; 208: 193-203.
14. Lijnen P., Petrov V. Cholesterol modulation of transmebrane transport systems in human erythrocytes. Biochem Mol Med. 1995 ; 56: 52-62.
15. Lijnen P., Petrov V., Amery A. Relationship between erythrocyte cation transport systems and membrane and plasma lipids in healthy men. Am J Med Sci. 1994 ; 307 (Suppl 1). S146 - S149.
16. Worley RJ, Hentschel WM, Cormier C., et al. Increased sodium-lithium countertransport in erythrocytes of pregnant women. N Eng J Med. 1982 ; 307: 412-416.
17. Dowd A., Thomas TH, Wilkinson R. Increased human erythrocyte sodium-lithium countertransport in hyperlipidemic patients may indicate increased membrane lipid fluidity. Eur J Clin Invest. 1993 ; 23: 102-107.
18. Rutherford PA, Thomas TH, Laker MF, Wilkinson R. Plasma lipids affect maximum velocity not sodium affinity of human sodium-lithium countertransport: distinction from essential hypertension. Eur J Clin Invest. 1992 ; 22: 719-724.
19. Macleod MJ, Lee WK, Devlin AM, et al. Sodium-lithium countertransport, sodium-hydrogen exchange and membrane microviscosity in patients with hyperlipidaemia. Clin Sci. 1997 ; 92: 237-246.
20. Wierzbicki AS, Hardman TC, Cheung J., et al. Effects of lipids in patients with familial hypercholesterolaemia on the kinetics of the sodium-lithium countertransporter. J Hum Hypertens. 2000 ; 14: 561-565.
21. Carr SJ, Thomas TH, Laker MF, Wilkinson R. Elevated sodium-lithium countertransport: a familial marker of hyperlipidaemia and hypertension ? J Hypertens. 1990 ; 8: 139-146.
22. Corrocher R., Steinmayr M., Ruzzenente O., et al. Elevation of red cell sodium-lithium countertransport in hyperlipidaemias. Life Sci. 1985 ; 36: 649-655.
23. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002 ; 106: 3143-3421.
24. Van Norren K., Thien T., Berden JH, Elving LD, De Pont JJ Relevance of erythrocyte Na+/Li+ measurement in essential hypertension, hyperlipidemia, and diabetic nephropathy: a critical review. Eur J Clin Invest. 1998 ; 28: 339-352.
25. Wierzbicki AS, Hardman TC, Cheung J., et al. Relation between sodium-lithium countertransport and hypertriglyceridemia in type V hyperlipidemia. Am J Hypetens. 2001 ; 14: 32-37.
26. Krzesinski JM, Saint-Remy A., Rorive G. Red blood cell Na-Li countertransport, hypertensive heredity, and cardiovascular risk in young adults. Am J Hypertens. 1993 ; 6: 314-316.
27. Saitta A., Castaldo M., Sardo A., et al. Effect of fluvastatin treatment on red blood cell Na+ transport systems in hypercholesterolemic subjects. J Cardiovasc Pharmacol. 2000 ; 35: 376-382.
28. Carr SJ, Thomas TH, Laker MF, Wilkinson R. Lipid-lowering therapy leads to a reduction in sodium-lithium countertransport activity. Atherosclerosis. 1991 ; 87: 103-108.
29. Rutherford PA, Thomas TH, Laker MF, Wilkinson R. Plasma lipids affect maximum velocity not sodium affinity of human sodium-lithium countertransport: distinction from essential hypertension. Eur J Clin Invest. 1992 ; 22: 719-724.
30. Pagano E., Siani A., Pauciullo P., et al. Effect of dietary versus pharmacological correction of hypertriglyceridemia on red blood cell membrane sodium/lithium countertransport activity. Life Sci. 1997 ; 60: 2389-2397.
31. Wierzbicki AS Statins and hypertension. J Hum Hypertens. 2006 ; 20: 554-556.
32. Milionis HJ, Liberopoulos EN, Achimastos A., Elisaf MS, Mikhailidis DP Statins: another class of antihypertensive agents ? J Hum Hypertens. 2006 ; 20: 320-335.
33. Kosmidou M., Hatzitolios A., Adamidou A., et al. Effects of atorvastatin on red blood cell Na+/Li+ countertransport in hyperlipidemic patients with and without hypertension. Am J Hypertens. 2008 ; 21: 303-309.
34. Weder AB, Serr C., Torretti BA, Bassett DR, Zweifler AJ Effects of lovastatin treatment on red blood cell and platelet cation transport. Hypertension. 1991 ; 17: 203-209.
35. Goulas A., Kosmidou M., Hatzitolios AI, et al. An association study of sodium-lithium countertransport activity with GST T1 and GST M1 null polymorphisms in Greek dyslipidemic patients and controls. Clin Chem Lab Med. 2008 ; 46: 306-310.
36. Goulas A., Kosmidou M., Hatzitolios AI, et al. Glutathione S-Transferase null and Cholesteryl Ester transfer protein TaqI B polymorphisms and lipid response to atorvastatin in Greek dyslipidemic patients [published online ahead of print March 6, 2008]. Basic Clin Pharmacol Toxicol. doi:10.1111/j.1742-7843. 2008.00220.x.
37. Trevisan M., Laurenzi M. Correlates of sodium-lithium countertransport. Findings from the Gubbio epidemiological study. The Gubbio Collaborative Study Group. Circulation. 1991 ; 84: 2011-2019.
38. Ragone E., Strazzullo P., Siani A., et al. Essential hypertension, impaired glucose tolerance, and hyperlipidemia: multiple relationships with sodium-lithium countertransport. J Hypertens. 1993 ; 11 (Suppl 5). S256 - S257.
39. Strazzullo P., Cappuccio FP, Trevisan M., et al. The relationship of erythrocyte sodium-lithium countertransport to blood pressure and metabolic abnormalities in a sample of untreated middle-aged male workers. J Hypertens. 1993 ; 11: 815-822.
40. Tepper T., Sluiter WJ, Huisman RM, de Zeeuw D. Erythrocyte Na+/Li+ countertransport and Na+/K+-2Clco-transport measurement in essential hypertension: useful diagnostic tools or failure? A meta-analysis of 17 years of literature. Clinic Sci (Lond). 1998 ; 95: 649-657.
41. Turner ST, Weidman WH, Michels VV, et al. Distribution of sodium-lithium countertransport and blood pressure in Caucasians 5 to 89 years of age. Hypertension. 1989 ; 13: 378-391.
42. Engelmann B., Duhm J., Schonthier UM, Streich S. Relations of sodium-lithium countertransport kinetics to plasma and red cell membrane phospholipids in hyperlipidemia. Atherosclerosis. 1993 ; 99: 151-163.
43. Chi Y., Mota de Freitas D., Sikora M., Bansal VK Correlations of Na+/Li+ exchange activity with Na+ and Li+ binding and phospholipids composition in erythrocyte membranes of white hypertensive and normotensive individuals: a nuclear resonance investigation. Hypertension. 1996 ; 27: 456-464.
44. Boerwinkle E., Turner ST, Weinshilboum R., Johnson M., Richelson E., Sing CF Analysis of the distribution of erythrocyte sodium lithium countertransport in a sample representative of the general population. Genet Epidemiol. 1986 ; 3: 365-378.
45. Weder AB, Schork NJ Mixture analysis of erythrocyte sodium-lithium countertransport and blood pressure. Hypertension. 1989 ; 13: 145-150.
46. Hasstedt SJ, Camp NJ, Hopkins PN, et al. Model-fitting and linkage analysis of sodium-lithium countertransport. Eur J Hum Genet. 2004 ; 12: 1055-1061.
47. Wierzbicki AS, Hardman TC, Cheung J., et al. The apolipoprotein E2 allele modulates activity and maximal velocity of the sodium-lithium countertransporter. Am J Hypertens. 2002 ; 15: 633-637.
48. West IC, Rutherford PA, Thomas TH Sodium-lithium countertransport: physiology and function. J Hypertens. 1998 ; 16: 3-13.
49. Williams RR, Hunt SC, Kuida H., Smith JB, Ash KO Sodium-lithium countertransport in erythrocytes of hypertension-prone families in Utah. Am J Epidemiol. 1983 ; 118: 338-344.
50. Strazzullo P., Siani A. Na-Li countertransport and ethnicity [Letter]. Am J Hypertens. 1999 ; 12: 434-435.